End-to-End Solutions for Process Intensification (PI): Expedite and De-risk implementation of early-stage PI Manufacturing Capacity with Sartorius ProcessGo

About the lecture 

With Process Intensification (PI) industry strives for more efficient manufacturing with lower costs of goods and lower (environmental) footprint. In this presentation, we demonstrate how to implement advanced PI technologies with minimal risk and maximal learning from established best practices through leveraging the know-how and technologies from state-of-the-art industry suppliers.

Sartorius ProcessGo®, which represent standardized, yet flexible, End-to-End PI process solutions, are a solid foundation to build your PI process strategies with the latest technologies and automation strategies. And they can be delivered rapidly, at affordable pricing, while have fully secured supply chains due to functional standardization. As such the need for (highly) customized solutions, which are not only more expensive, but also create future supply chain risks, is avoided.

About the speaker

Gerben is a regular speaker on Process Intensification (PI) and continuous biomanufacturing. He received his Ph.D. from the WUR in the field of process integration in animal cell culture and he has worked for more than 25 years in the BioPharma Industry in the CDMO business and on PI in SU bioreactors at DSM Biologics. He invented XD® (cFB) technology, boosting yield up to 5-fold. As a Sr. Consultant at Xendo, he has worked on cutting edge SU-PI, and Gene Therapy projects. Aa Process Technology Manager at Sartorius he drives the further improvement of the Sartorius PI technology portfolio for the advancement the BioPharma industry.

About Sartorius

We are living in the bio-century. Global medical knowledge is expanding at a rapid pace. But despite huge breakthroughs, many diseases, such as cancer, rheumatism or Alzheimer's, are still not curable. Sartorius is part of the solution. They help to ensure that new scientific discoveries can be translated more quickly into effective patient care. With technologies, platforms and partnerships for a common goal: better health for more people.

Collaboration Sartorius and Enzene Biosciences Ltd

Enzene is a company focused on impacting global healthcare by delivering trusted and affordable medicine for a better quality of life. They are doing this by innovating new solutions for continuous biomanufacturing. Biomanufacturing is a complicated process by nature, and it’s made more complex by the unique regulatory challenges it faces. With help from Sartorius, Enzene is working to develop a platform for innovation in India.

Today, Enzene and Sartorius are continuing their collaboration in an ongoing effort to develop therapeutics that are as accessible as possible to patients in countries like India, as well as the global market.